Physiotherapy for Urinary Incontinence in Gynecologic Cancer Survivors
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial examines the effectiveness of physiotherapy (also known as Pelvic Floor Physical Therapy or Pelvic Health Physiotherapy) for women who have had gynecological cancer and experience urinary incontinence. It compares a 12-week physiotherapy program to the usual care provided by doctors. The trial targets women who have completed cancer treatments and experience stress or mixed urinary incontinence at least three times a week. The goal is to determine if physiotherapy can reduce these leaks and improve quality of life. As an unphased trial, this study offers a unique opportunity to explore new methods to enhance recovery and quality of life after cancer treatment.
Do I need to stop my current medications for this trial?
The trial protocol does not specify whether you need to stop taking your current medications.
Do I need to stop my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that physiotherapy is safe for gynecologic cancer survivors with urinary incontinence?
Research has shown that physiotherapy is generally safe for people with urinary incontinence. It often includes exercises like pelvic floor muscle training, which addresses pelvic floor issues. These exercises are typically easy to perform and don't cause problems for most individuals.
Studies have found that pelvic floor muscle training benefits women who have had gynecological cancer, helping them manage urinary incontinence after treatment. Importantly, no major negative side effects have been reported from these exercises.
This type of physiotherapy can also be conducted through telehealth (remote healthcare), with patients managing well without serious issues. Overall, physiotherapy remains a safe option for those dealing with urinary incontinence after gynecological cancer.12345Why are researchers excited about this trial?
Researchers are excited about physiotherapy for urinary incontinence in gynecologic cancer survivors because it offers a non-invasive, drug-free alternative to traditional treatments like medication or surgery. Unlike other treatments that often focus on managing symptoms, physiotherapy aims to improve pelvic floor strength and function, potentially addressing the root cause of incontinence. This approach not only enhances physical health but also empowers survivors with self-management techniques, promoting long-term well-being.
What evidence suggests that physiotherapy is effective for urinary incontinence in gynecologic cancer survivors?
Research has shown that physiotherapy can help manage urinary incontinence in women who have survived gynecologic cancer. In this trial, participants will join either a physiotherapy group or a standard usual care group. One effective method under study is pelvic floor muscle training, a type of physiotherapy that helps control symptoms and improve quality of life. Studies have found that these exercises effectively treat pelvic floor problems, which are common after cancer treatment. Additionally, delivering physiotherapy via telehealth has proven effective for treating incontinence after surgery. Overall, these findings suggest that physiotherapy offers a promising way to manage urinary incontinence in this group.12367
Are You a Good Fit for This Trial?
This trial is for women who have survived gynecological cancers like endometrial or cervical cancer and are now experiencing urinary incontinence at least three times a week. They should be done with their scheduled cancer treatments but haven't had pelvic floor rehab in the past year, and don't have other conditions that could affect the study.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either 12-weekly physiotherapy treatment sessions or continue standard usual care for 12 weeks
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Physiotherapy
Physiotherapy is already approved in European Union, United States, Canada for the following indications:
- Urinary incontinence in gynecological cancer survivors
- Pelvic pain
- Sexual dysfunction
- Urinary incontinence in gynecological cancer survivors
- Pelvic pain
- Sexual dysfunction
- Urinary incontinence in gynecological cancer survivors
- Pelvic pain
- Sexual dysfunction
Find a Clinic Near You
Who Is Running the Clinical Trial?
Université de Sherbrooke
Lead Sponsor
Centre hospitalier de l'Université de Montréal (CHUM)
Collaborator
Centre de recherche du Centre hospitalier universitaire de Sherbrooke
Collaborator
Institut Universitaire de Gériatrie de Montréal
Collaborator
Jewish General Hospital
Collaborator